105 related articles for article (PubMed ID: 21338454)
1. Do the national survey results reflect the state of drug-induced liver injury in a single local city in which there is no hospital having Members of the Board of Councilors of the Japan Society of Hepatology? Results of a questionnaire survey conducted in a local city.
Hisamochi A; Kumashiro R; Sata M
Hepatol Res; 2011 Mar; 41(3):225-32. PubMed ID: 21338454
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan.
Aiso M; Takikawa H; Tsuji K; Kagawa T; Watanabe M; Tanaka A; Sato K; Sakisaka S; Hiasa Y; Takei Y; Ohira H; Ayada M; Hashimoto E; Kaneko S; Ueno Y; Ohmoto K; Takaki A; Torimura T; Matsuzaki Y; Tajiri K; Yoneda M; Ito T; Kato N; Ikejima K; Mochida S; Yasuda H; Sakamoto N
Hepatol Res; 2019 Jan; 49(1):105-110. PubMed ID: 30565816
[TBL] [Abstract][Full Text] [Related]
3. Does the Japanese Society for Hygiene need its own Code of Conduct? A comparison of the responses of councilors and junior members based on a questionnaire survey.
Ikeda W; Inaba Y; Takeshita T; Yoshida K; Ogoshi K; Okamoto K
Environ Health Prev Med; 2011 May; 16(3):178-84. PubMed ID: 21431804
[TBL] [Abstract][Full Text] [Related]
4. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics of Patients with Drug-induced Liver Injury.
Yang LX; Liu CY; Zhang LL; Lai LL; Fang M; Zhang C
Chin Med J (Engl); 2017 Jan; 130(2):160-164. PubMed ID: 28091407
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and pathological features in 138 cases of drug-induced liver injury].
Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
[TBL] [Abstract][Full Text] [Related]
7. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
8. Presentation of drug-induced liver injury in Singapore.
Wai CT
Singapore Med J; 2006 Feb; 47(2):116-20. PubMed ID: 16435052
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of drug-induced liver injury in the elderly.
Onji M; Fujioka S; Takeuchi Y; Takaki T; Osawa T; Yamamoto K; Itoshima T
Hepatol Res; 2009 Jun; 39(6):546-52. PubMed ID: 19254343
[TBL] [Abstract][Full Text] [Related]
10. Necrotic cell death and suppression of T-cell immunity characterized acute liver failure due to drug-induced liver injury.
Kakisaka K; Kataoka K; Suzuki Y; Okada Y; Yoshida Y; Kuroda H; Takikawa Y
Cytokine; 2016 Oct; 86():21-28. PubMed ID: 27442007
[TBL] [Abstract][Full Text] [Related]
11. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
Dobrić I
Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
[TBL] [Abstract][Full Text] [Related]
12. Review article: drug-induced liver injury in clinical practice.
Björnsson E
Aliment Pharmacol Ther; 2010 Jul; 32(1):3-13. PubMed ID: 20374223
[TBL] [Abstract][Full Text] [Related]
13. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
[TBL] [Abstract][Full Text] [Related]
14. The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware.
Vega M; Verma M; Beswick D; Bey S; Hossack J; Merriman N; Shah A; Navarro V;
Drug Saf; 2017 Sep; 40(9):783-787. PubMed ID: 28555362
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury.
Tsutsui A; Nakanuma Y; Takaguchi K; Nakamura S; Shibata H; Baba N; Senoh T; Nagano T; Ikeda H
Mediators Inflamm; 2015; 2015():913793. PubMed ID: 26783385
[TBL] [Abstract][Full Text] [Related]
16. Risk of drug-induced liver injury from tumor necrosis factor antagonists.
Björnsson ES; Gunnarsson BI; Gröndal G; Jonasson JG; Einarsdottir R; Ludviksson BR; Gudbjörnsson B; Olafsson S
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):602-8. PubMed ID: 25131534
[TBL] [Abstract][Full Text] [Related]
17. Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury.
Pang L; Yang W; Hou F
Clin Res Hepatol Gastroenterol; 2018 Feb; 42(1):48-56. PubMed ID: 28927656
[TBL] [Abstract][Full Text] [Related]
18. [Current concepts and morphological aspects of drug induced liver injury].
Ehrmann J; Strojil J
Cesk Patol; 2008 Jan; 44(1):4-7. PubMed ID: 18333326
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006.
Takikawa H; Murata Y; Horiike N; Fukui H; Onji M
Hepatol Res; 2009 May; 39(5):427-31. PubMed ID: 19207579
[TBL] [Abstract][Full Text] [Related]
20. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.
Lammert C; Einarsson S; Saha C; Niklasson A; Bjornsson E; Chalasani N
Hepatology; 2008 Jun; 47(6):2003-9. PubMed ID: 18454504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
